Harbour Investments
RXRX icon

Harbour Investments’s Recursion Pharmaceuticals RXRX Stock Holding History

Harbour Investments’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.53K Buy
2,053
+684
+50% +$2.28K ﹤0.01% 3500
2026
Q1 		$4.21K Buy
1,369
+73
+6% +$282 ﹤0.01% 3651
2025
Q4 		$5.3K Hold
1,296
– – ﹤0.01% 2996
2025
Q3 		$6.32K Hold
1,296
– – ﹤0.01% 2892
2025
Q2 		$6.56K Sell
1,296
-100
-7% -$491 ﹤0.01% 2763
2025
Q1 		$7.38K Buy
1,396
+396
+40% +$2.89K ﹤0.01% 2661
2024
Q4 		$6.76K Hold
1,000
– – ﹤0.01% 2618
2024
Q3 		$6.59K Buy
+1,000
New +$7.17K ﹤0.01% 2530

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Harbour Investments's RXRX Position: Q2 2026 in Review

Harbour Investments increased its Recursion Pharmaceuticals (RXRX) stake by 50% in Q2 2026, buying an estimated $2.28K and bringing the position to 2,053 shares worth $7.53K. The position accounts for ﹤0.01% of the portfolio, ranked #3500.

Harbour Investments first reported a position in RXRX in Q3 2024 and has held it in 8 quarters since. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Harbour Investments held 2,053 shares of Recursion Pharmaceuticals worth $7.53K as of Q2 2026.
  • Harbour Investments bought 684 Recursion Pharmaceuticals shares in Q2 2026, an estimated $2.28K.
  • Recursion Pharmaceuticals made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3500 holding.
  • Harbour Investments first reported a position in Recursion Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.